In prostate cancer, for example, suppressing the epigenetic regulator chromatin remodeling proteinHMGA2 with a histone deacetylase (HDAC) inhibitor inhibits EMP and significantly reduces tumor growth and metastasis (28). This evidence concerns the gene MAEA and prostate cancer.